Poland?s second largest publicly traded building company Polimex-Mostostal Siedlce plans to boost its sales through organic growth and new acquisitions, chief executive Konrad Jaskóła said in an interview with PARKIET. It is looking for new road and railway construction companies, Jaskóła said, after the failed acquisition of PRInż, southern Poland?s biggest road construction group.
Polimex is also looking at new markets, including residential property development project in Ukraine and in major Polish cities, Jaskóła said.
He added that he isn?t worried about his company being a takeover target because of growing market capitalization. Shares of Polimex closed at 48.8 zloty, up 1.88 percent on Friday giving the company market value of approximately 900 million zloty.
Pharmaceuticals
Bioton sees higher sales in Russia and East Asia
Drug-maker Bioton S.A., a Polish pharmaceutical company that styles itself as the only Central European biotechnology stock says it expects a boost in sales and earnings from subsidiaries in Russia and in the Far East. Bioton, whose shares rose nearly 70 percent over the last few weeks, said it may present a revised earnings forecast along with third-quarter earnings report, due before November 15.